SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-17-005811
Filing Date
2017-09-13
Accepted
2017-09-13 16:05:14
Documents
6
Period of Report
2017-10-26
Effectiveness Date
2017-09-13

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2233237zdef14a.htm DEF 14A 752094
2 G460485.JPG g460485.jpg GRAPHIC 13363
3 G316290.JPG g316290.jpg GRAPHIC 3705
4 G893572.JPG g893572.jpg GRAPHIC 5930
5 G209214BGI001.GIF g209214bgi001.gif GRAPHIC 182276
6 G209214BGI002.GIF g209214bgi002.gif GRAPHIC 130568
  Complete submission text file 0001047469-17-005811.txt   1216070
Mailing Address 3200 WALNUT STREET BOULDER CO 80301
Business Address 3200 WALNUT STREET BOULDER CO 80301 3033816600
ARRAY BIOPHARMA INC (Filer) CIK: 0001100412 (see all company filings)

IRS No.: 841460811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: DEF 14A | Act: 34 | File No.: 001-16633 | Film No.: 171083237
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1